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Abstract. Phosphorylation of keratin polypeptides 8 
and 18 (K8/18)  and other intermediate filament pro- 
teins results in their reorganization in vitro and in vivo. 
In order to study functional aspects of human K18 
phosphorylation, we generated and purified a poly- 
clonal antibody (termed 3055) that specifically recog- 
nizes a major phosphorylation site (ser52) of human 
K18 but not dephosphorylated K18 or a ser52~ala K18 
mutant. Pulse-chase experiments followed by immuno- 
precipitation and peptide mapping of in vivo 32po 4- 
labeled  K8/18 indicated that the overall phosphoryla- 
tion turnover rate is faster for K18 versus K8, and that 
ser52 of K18 is a highly dynamic phosphorylation site. 
Isoelectric focusing of 32po 4 labeled K18 followed by 
immunoblotting with 3055 showed that the major phos- 
phorylated K18 species contain ser52 phosphorylation 
but that some K18 molecules exist that are preferen- 
tially phosphorylated on K18 sites other than ser52. Im- 
munoblotting of total cell lysates obtained from cells at 
different stages of the cell cycle showed that ser52 
phosphorylation increases three to fourfold during the 
S and G2/M phases of the cell cycle. Immunofluores- 
cence staining of cells at different stages of mitosis, us- 
ing 3055 or other antibodies that recognize the total 
keratin pool, resulted in preferential binding of the 
3055 antibody to the reorganized keratin fraction. 
Staining of human tissues or tissues from transgenic 
mice that express human K18 showed that the phos- 
pho-ser52 K18 species are located preferentially in the 
basolateral and apical domains in the liver and pan- 
creas, respectively, but no preferential localization was 
noted in other simple epithelial organs examined. Our 
results support a model whereby phosphorylated inter- 
mediate filaments are localized in specific cellular do- 
mains depending on the tissue type and sites(s) of phos- 
phorylation. In addition, ser52 of human K18 is a highly 
dynamic phosphorylation site that undergoes modula- 
tion during the S and G2/M phases of the cell cycle in 
association with filament reorganization. 
I 
NTERMEDIATE filament (IF)  1 proteins make up a large 
family of cytoskeletal proteins whose importance is 
accumulating as mutations in these proteins are in- 
creasingly  recognized as the cause of several  human dis- 
eases  (reviewed by Fuchs and Coulombe, 1992; Steinert 
and  Bale,  1993; Fuchs et  al.,  1994; McLean and  Lane, 
1995). An important feature of IF proteins is their tissue 
preferential expression  (reviewed  by  Moll  et  al.,  1982; 
Steinert and Roop, 1988; Fuchs and Weber, 1994). For ex- 
ample, the type I and type II keratin subfamily of IF pro- 
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teins are expressed in epithelial cells; type III vimentin and 
glial  fibrillary  acidic  protein  (GFAP)  are  expressed  in 
mesenchymal and  glial  cells,  respectively;  and  type  IV 
neurofilaments (NF)  are expressed  in most neurons. The 
keratin IF proteins consist of at least twenty unique gene 
products that correspond to the relatively acidic  type I 
(K9-K20) and basic type II (K1-K8) members. All epithe- 
lial cells express, as obligate noncovalent heteropolymers, 
at least one type I and one type II keratin as their major IF 
proteins in an epithelial tissue-preferential manner. For 
example,  K8/18 and K5/14 are found in simple glandular 
and epidermal epithelia,  respectively,  and other keratin 
pairs  are found in other tissues  in varying combinations 
(Moll et al., 1982). 
Although the function of IF proteins as a group is still 
poorly understood, the most likely candidates for regulat- 
ing the function of IF proteins are IF associated  proteins 
and posttranslational modifications.  With regard  to  the 
latter, IF glycosylation has been studied to a limited extent 
(King and Hounsell, 1989; Chou et al., 1992; Dong et al., 
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somewhat better understood with some in vivo and exten- 
sive in vitro data showing that it plays an important role in 
filament reorganization. For example, in vitro phosphory- 
lation of K8/18 (Yano et al.,  1991b), vimentin (Inagaki et 
al., 1987), desmin (Inagaki et al., 1988), and NF (Gonda et 
al., 1990) by a number of kinases results in filament disas- 
sembly. Furthermore, mutation of the major physiologic 
phosphorylation site (ser52) of human K18 interfered with 
the  ability  of transfected  K8/18  filaments  to  reorganize 
upon G2/M cell cycle arrest using colcemid or upon treat- 
ment of cells with okadaic acid (Ku and Omary, 1994).  In 
addition to a role of filament reorganization, IF phospho- 
rylation appears to be important in defining specific sub- 
cellular localization of the phosphorylated subspecies un- 
der dynamic or steady states. For example, phosphorylated 
NF are preferentially found in the axon in contrast with 
the  nonphosphorylated  NF  which  are  relatively  more 
abundant in the cell body and dendrites (Sternberger and 
Sternberger, 1983;  Lee et  al.,  1987).  In  addition,  GFAP 
species that are phosphorylated on ser 13 and 34 and thr 7 
are preferentially located at the cleavage furrow during cy- 
tokinesis (Matsuoka et al., 1992). 
K8/18 phosphorylation (Celis et al., 1983) occurs nearly 
exclusively on serines and increases as determined by met- 
abolic labeling, in association with colcemid induced mi- 
totic arrest (Chou and Omary, 1993), heat stress, or rotavi- 
rus infection of epithelial cells (Liao et al.,  1995b), the S 
and  G2/M  stages  of the  cell cycle in  synchronized cells 
(Chou and Omary, 1994), and after treatment with oka- 
daic acid (Ku and Omary, 1994). Phosphorylation and gly- 
cosylation occur on different K8/18 molecules (Chou and 
Omary, 1993), and altering one modification does not ap- 
pear to affect the other which suggests that each modifica- 
tion is likely to have its own function(s) (Ku and Omary, 
1994). In this report we compared the turnover rate of K8 
and K18 phosphorylation then focused on K18 phosphory- 
lation by developing a polyclonal antibody that is specific 
for the  phospho-ser52  containing moiety of K18.  Using 
this  phosphorylated  epitope-specific antibody,  we  show 
that K18 ser52 phosphorylation increases three- to four- 
fold during the S and G2/M stages of the cell cycle, and 
that the reorganized fraction of K8/18 filaments is prefer- 
entially phosphorylated as compared with the overall K8/ 
18 pool. We also show that similar to the polar distribution 
pattern  of  phosphorylated  neurofilaments  in  neurons, 
ser52  phosphorylated  K18  is  preferentially localized  in 
specific cellular domains in some tissues, depending on the 
tissue examined. 
Materials and Methods 
Reagents Cells and Tissues 
Human colon HT29 cells were obtained from the American Type Culture 
Collection  (Rockville,  MD),  and  cultured  human  keratinocytes  were 
kindly provided by Dr. Warren Hoeffler (Stanford University, Stanford, 
CA). Carrier-free orthophosphate (32po4)  was purchased from DuPont- 
New England Nuclear (Boston, MA). Antibodies used in this study were 
L2A1 (Chou and Omary, 1993) and CK5 (Sigma Chemical Co., St. Louis, 
MO), which are mAbs directed against human K18;  and 3055,  a  rabbit 
polyclonal antibody to a  phosphoserine-containing human K18 peptide 
(see below). Other reagents used were: okadaic acid (LC Services, Woburn, 
MA); polyvinylidene difluoride (PVDF) membranes (Millipore Corpora- 
tion, Bedford, MA); nocodazole, aphidicolin, NP-40, and Freund's adju- 
vant (Sigma Chemical Co.); potato acid phosphatase (Boehringer Mann- 
heim  Biochemicals,  Indianapolis,  IN);  keyhole  limpet  hemocyanin, 
M-maleimidobenzoyl-N-hydroxysuccinimide ester  (MBS),  Reduce-Imm 
Reducing  Kit,  and  ImmunoPure  Ab/Ag  Immobilization  Kit  (Pierce, 
Rockford, IL); Empigen BB (CalBiochem-Behring Corp., La Jolla, CA); 
and enhanced chemiluminescence (ECL) reagents (Amersham Corp., Ar- 
lington Heights, IL). Transgenic mice that express wild type human K18 in 
a tissue specific manner (Abe and Oshima, 1990) were kindly provided by 
Dr. Robert Oshima (La Jolla Cancer Research Foundation, La Jolla, CA). 
Fresh frozen human tissues were obtained from the NCI Cooperative Hu- 
man Tissue Network (Colombus, OH). 
Peptide Synthesis and Anti-phosphopeptide 
Antibody Generation 
Peptide synthesis was carried out using an automated Milligen Peptide 
Synthesizer and  FMOC-Cys Novasyn KA100  resin. The  free  hydroxyl 
group of serine was phosphorylated using dibenzyl-N-N-diethyl  phosphor- 
amidate as described (Otvos et al., 1989; Andrews et al., 1991). The crude 
phosphopeptide was purified using reverse phase HPLC (3.9  ×  300 mm 
C18 column) and a linear gradient containing 0.05 % trifluoroacetic acid in 
15~65%  acetonitrile. The yield of the purified phosphopeptide was 50% 
(which elutes first) and purity of the HPLC purified product was con- 
firmed using mass spectrometry (mass =  1367.92). The purified phospho- 
peptide 47VSRSTS(POg)FRGGMC  or  an  identical  nonphosphorylated 
peptide were coupled to keyhole limpet hemocyanin using MBS. Cys was 
included at the COOH terminus of the peptide to allow coupling to the 
carrier.  Rabbits  were  immunized  (intramuscularly,  intradermally,  and 
subcutaneously) at monthly intervals which provided high titer antibodies 
after four immunizations. 
For antibody purification, the phosphorylated and nonphosphorylated 
peptides were reduced using the Reduce-Imm Reducing Kit and coupled 
to Sulfolink  TM columns (via the COOH-terminal cysteine residue) as rec- 
ommended by the manufacturer. The peptide-coupled columns were then 
sequentially washed with 10 bed volumes of 10 mM Tris-HCl (pH 7.5), 100 
mM glycine (pH 2.5),  10 mM Tris-HCl (pH 8.8),  100 mM triethylamine 
(pH 11), and 10 mM Tris-HC1  (pH 7.5). Serum from the phosphopeptide 
immunized rabbits (4 ml diluted 1:10 in 10 mM Tris-HC1,  pH 7.5)  was 
passed over the nonphosphorylated-peptide column three times to remove 
antibodies that  bind  to  nonphosphorylated epitopes, then  passed two 
times over the phosphorylated-peptide column. The column was washed 
with 20 bed volumes of 10 mM Tris-HC1  (pH 7.5)  and 10 mM Tris-HC1/ 
500 mM NaC1 (pH 7.5), followed by elution of the antibody using 10 bed 
volumes of 100 mM glycine (pH 2.5) with immediate neutralization using 
5 ml of 1 M Tris-HCl (pH 8.0). The purified anti-phosphopeptide antibody 
(termed 3055 Ab) was concentrated then dialyzed against PBS. 
Cell Culture and Synchronization 
HT29 cells were grown in RPMI 1640 medium supplemented with 10% fe- 
tal bovine serum, 100 U/ml penicillin, and 100 ~,g/ml streptomycin at 37°C 
(standard medium). Near-confluent cells were synchronized at the G1/S 
boundary by incubation with 5 ~tg/ml aphidicolin for 24 h. S phase and G2/ 
M-enriched cells were then obtained by washing off the aphidicolin, split- 
ting the cells 1:3, and then culturing in standard medium for different 
times. Cells were arrested at the G2/M boundary by treatment with colce- 
mid (0.5 p,g/ml, 36 h) as described (Chou and Omary, 1993). Heat stress of 
HT29 cells (at 50% confluency) was carried out by culturing at 42°C for 24 h 
(Liao et al., 1995a). Cell cycle analysis was carried out as described (Chou 
and Omary, 1994). 
Immunoprecipitation, Dephosphorylation, Western 
Blotting, and Gel Analysis 
Cells were harvested, washed in PBS, and solubilized in PBS containing 1% 
NP-40 or 1% Empigen BB (Emp) and 0.1 mM phenylmethanesulphonyl 
fluoride, 10 ~M pepstatin A, 10 IxM leupeptin, 25 txg/ml aprotinin (4°C, 45 
min), and 0.5 ~g/ml okadaic acid. Insoluble material was pelleted and the de- 
tergent lysates were used for immunoprecipitation or Western blotting. 
Emp provides significantly  higher yields of solubilized keratins than NP-40 
(Lowthert et al., 1995). Detergent lysates (0.2-1.2 ml) were mixed with aga- 
rose-coupled L2A1 (20-60/~l) and incubated with shaking (2 h), washed 5 × 
in the solubilization detergent, followed by SDS-PAGE (Laemmli, 1970). 
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stressed (42°C) cells by immunoprecipitation followed by electroelution of 
the K18 band, was carried out using 3 txg potato acid phosphatase (PAP) 
in 10 txl of 40 mM Pipes (pH 6.0) and 1 mM DTT for I h (22°C). Immuno- 
blotting was done  after separating lysates or immunoprecipitates using 
SDS-PAGE, and then transferring to PVDF membranes (4°C, 40 V, 12-16 
h). Membranes were blocked in 5%  nonfat dry milk/0.2% Tween 20 in 
PBS (MT) for 2 h at room temperature, and then incubated with the pri- 
mary antibody diluted in MT (1:1,000  for CK5 or L2A1 ascites, 2 Ixg/ml 
for purified 3055 antibody) for 1 h. After washing, membranes were incu- 
bated in a 1:1,000 dilution of peroxidase-conjugated goat anti-mouse IgG 
(for the L2A1, CK5 primary antibodies), or peroxidase-conjugated goat 
anti-rabbit IgG (for the 3055 Ab) for 1 h, and then washed and visualized 
using an ECL system as recommended by the manufacturer. For the pep- 
tide competition experiments, Western blotting was carried out exactly as 
described except that the antibodies were preincubated with 150 t~g/ml of 
nonphosphorylated or  phosphorylated peptide  followed by  incubation 
with the blocked PVDF membrane. Two-dimensional gel electrophoresis 
was done using a gel apparatus (Mini-PROTEAN II; BioRad Laborato- 
ries, Cambridge, MA) exactly as recommended by the manufacturer. 
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Figure 1.  Turnover  of K8 and K18 phosphorylation. Subconflu- 
ent HT29 cells were labeled with 32po  4 for 30 min (250 ixCi/ml) in 
phosphate-free media followed by replacing the labeling media 
with normal RPMI 1640 containing 10%  fetal calf serum for the 
indicated  chase  hours.  Cells  were  then  solubilized followed by 
immunoprecipitation as described in Materials and Methods. The 
histogram  in  B  was  generated  after  scanning  the  Coosmassie- 
stained bands to correct for protein level, then counting the gel 
strips  that  correspond  to  K8,  K18,  and  an  equivalent  strip  as 
background from the same lane for each K8/18 pair. The percent 
cpm for each time point relative to the zero h  chase was calcu- 
lated as follows: ([cpm of keratin]  -  [background  cpm in  same 
lane]) +  ([cpm of keratin at 0 h  chase] -  [background cpm at 0 h 
chase])  ×  100.  The  cpm for K8  and  K18  (after  substraction  of 
background) at the 0 h chase were 460 and 109, respectively. Sim- 
ilar results were obtained in two other separate experiments. 
Radiolabeling, Peptide Mapping, and Stoichiometry of 
K8118 Phosphorylation 
For the pulse-chase experiment, cells were incubated in phosphate-free 
RPMI 1640 medium containing 10% dialyzed fetal bovine serum for 0.5 h, 
and then labeled for 30 min with 250 I~Ci/m132po  4. After the pulse, the la- 
bel-containing medium was replaced with normal RPMI 1640,  and the 
cells were chased for 0, l, 3, 4, or 6 h, followed by solubilization, immuno- 
precipitation, and SDS-PAGE analysis. Relative K8 and K18 protein levels 
were determined by scanning the wet destained gel using a  Pharmacia- 
LKB Laser Densitometer. The gel was then dried and exposed to film fol- 
lowed by cutting out and counting K8, K18 and background-containing 
gel fragments to determine the specific activity of K8 and K18 labeling. 
Tryptic phosphopeptide mapping was performed using keratins puri- 
fied from cells (asynchronous [G cells]; G2/M colcemid arrested [M cells]; 
heat stressed [24 h, 42°C]; or cells treated with okadaic acid [OA]) that 
were labeled for 11 h with 250 ixCi/m132po 4 in the presence of 55 p,M cold 
phosphate. Alternatively, cells were similarly labeled for 5 h (for the K18 
ser52-containing peptide turnover experiment) then incubated in standard 
medium for 0, 3, or 6 h. Cells were solubilized followed by immunoprecip- 
itation of K8/18. Tryptic peptide mapping was done as described (Boyle et 
al.,  1991; Chou et al., 1993). Briefly, individual K8 and K18 were excised 
from preparative SDS-PAGE gels after brief Coomassie blue  staining, 
and  then  electroeluted  and  acetone  precipitated.  The  keratins  were 
treated with trypsin (375 ~g/ml in 80 i-tl of 50 mM NH4HCO3)  for 16 h, ly- 
ophilized, and then electrophoresed in the horizontal dimension, followed 
by chromatography in the vertical dimension. Where indicated, the rela- 
tive radioactivity incorporated into individual phosphopeptides  was deter- 
mined by densitometric scanning of the peptide map autoradiographs. 
The stoichiometry of K8 and K18 phosphorylation in HT29 cells was de- 
termined using purified K8 and K18 that were separated by preparative 
SDS-PAGE  followed by  electroelution. Phosphate  content was  deter- 
mined by ashing as described (Vacquier and Moy, 1991). 
Immunofluorescence 
HT29 cells were grown on coverslips, fixed in methanol (3 min, -20°C), 
washed once in PBS, followed by blocking with PBS containing 2.5% BSA 
(10 rain). Tissues from mouse or human organs were frozen in O.C.T. com- 
pound (Miles, Elkhart, IN). Frozen sections were cut then fixed briefly in 
cold acetone. Fixed tissues or cells were then incubated with primary anti- 
body (CK5 or L2A1 ascites, 1:100; or 3055 Ab, 10 Ixg/ml in the presence or 
absence of 200 Ixg/ml peptide or phosphopeptide) for 30 min. After wash- 
ing in PBS/2.5% BSA, samples were blocked with 2% goat serum in PBS/ 
2.5%  BSA (15  rain), followed by incubation with Texas red goat anti- 
mouse (1:100; CK5 and L2A1 antibodies) or Texas red donkey (or goat) 
anti-rabbit (1:100;  3055  Ab) for 30 min. For DNA  and keratin double 
staining, YO-PRO-1 iodide (Molecular Probes, Eugene, OR; 1:20,000) was 
included with the second antibody and all steps were carried out in the 
presence of RNase A (0.5 mg/ml). Slides were washed five times with PBS 
and  photos were  taken  using Kodak  Ektachrome  color slide film from 
which black and white pictures were generated. 
Results 
Turnover of  K8 and K18 Phosphorylation 
Given that type I and type II keratins form obligate hetero- 
polymers, we examined the turnover of phosphorylation at 
two  levels: first,  overall individual  keratin phosphoryla- 
tion and, second, specific phosphopeptide phosphorylation. 
Overall  K8  and  K18  phosphorylation  was  assessed  by 
pulse  labeling  subconfluent  human  colonic  HT29  cells 
with  32po  4  for 30 min followed by chasing for different 
time points. As shown in Fig. 1, the turnover of K18 phos- 
phorylation is  significantly faster than  that of K8.  How- 
ever, if confluent cells were used for labeling, the turnover 
differences between K8 and K18 phosphorylation became 
less dramatic (not shown). The initial increase in K8 phos- 
phorylation after 1 h of chase is reproducible (n =  3) and 
suggests that the overall turnover of K8 phosphorylation is 
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early chase time point  is more  for K18 than  for K8.  Of 
note,  the  specific activity of radiolabeled  K8  is  approxi- 
mately four times greater than for K18, although the over- 
all stoichiometry of individual  K8 and K18 phosphoryla- 
tion after purification from confluent HT29 cells is 3.1 and 
1.4 molecules of phosphate per molecule of K8 and K18, 
respectively. 
Our previous studies  indicated  that ser52 is the  major 
phosphorylation site  of K18,  after metabolic labeling  of 
tissue cultured colonic tumor cell lines or normal human 
explant biopsies for 3 h with 32po  4 (Ku and Omary, 1994). 
Other phosphopeptides become apparent as the duration 
of metabolic labeling is increased  (not shown).  This sug- 
gested that ser52 of K18 is likely to be a  highly dynamic 
phosphorylation site. We addressed this possibility by la- 
beling HT29 cells with 32po  4 for 5 h then chasing for 0, 3, 
or 6 h in excess nonlabeled phosphate. As shown in Fig. 2 
A  (d-f),  ser52  shows  significant  relative  dephosphoryla- 
tion as compared with other K18 phosphopeptides. Using 
densitometric scanning, the phosphorylation ratio of ser52 
phosphopeptide/two  other K18 phosphopeptides is  1.5:1 
at the 0 h chase versus 0.5:1 at the 6 h chase. The two ma- 
jor K8 peptides show slightly different turnover rates (Fig. 
2 A, a-c), with the peptide indicated by an arrowhead (Fig. 
2 A, a) having a 1.5× faster turnover rate than the second 
major K8 peptide. In addition, there are two faint K8 pep- 
tides that appear after the 6 h chase (Fig. 2 A, indicated by 
arrows in c) which may represent slow turnover peptides 
or other more complex processes. Additional support for 
the rapid turnover of ser52 phosphorylation is the observa- 
tion that when cells are labeled with 32po  4 for 11 h  in the 
absence of supplemental "cold" phosphate (i.e., under phos- 
phate  starvation  conditions),  ser52  shows  minor  radio- 
labeling  as  compared  with  other  K18  phosphopeptides 
(not shown). 
Development of the 3055 Antibody Directed to the K18 
Phospho-ser52-containing Epitope 
Given that ser52 of K18 represents a highly dynamic phos- 
phorylation site, we proceeded to develop antibodies that 
specifically recognize this phospho-epitope to address func- 
tional questions regarding this phosphorylation site. Speci- 
ficity of the  generated  antibodies  (termed 3055  Ab) was 
confirmed at several levels. 
First, immunoblotting of wild type (WT) and ser52--~ala 
K18, both expressed then purified from Sf9 cells (Ku and 
Omary, 1994), using purified 3055  Ab showed that the an- 
tibody reactivity with WT K18 was abolished in the case of 
the ser52 mutant (Fig. 3 A, compare lanes 5  and 6). The 
3055 Ab reactivity is specifically abolished in the presence 
of the  phosphopeptide  used for immunization  (Fig.  3 A, 
lanes 7 and 8) but is not affected by the presence of pep- 
tide  alone  (Fig.  3  A,  lanes  5  and  6).  In  all  cases,  equal 
amounts of protein were analyzed as determined by Coo- 
massie staining (Fig. 3 A, lanes 1 and 2) and immunoblot- 
ting  using  antibodies  that  recognize  the  total  K18  pool 
(Fig. 3 A, lanes 3 and 4 for CK5 antibody, and not shown for 
L2A1 antibody). 
Secondly, we used the  3055  Ab to examine K18 ser52 
phosphorylation under conditions that previously showed 
overall K18 hyperphosphorylation. These include  mitotic 
arrest  (Chou  and  Omary, 1993),  heat  stress  (Liao et  al., 
1995b), and treatment with the phosphatase inhibitor oka- 
daic acid (Ku and Omary, 1994).  As shown in Fig. 3 B, a 
dramatic increase in K18 ser52 phosphorylation was noted 
Figure 2.  Turnover of K8 and K18 phosphopeptides and K18 tryptic phosphopeptide mapping. (A) HT29 cells were labeled for 5 h with 
32po  4 then chased for 0, 3, or 6 h in normal medium as described in Materials and Methods. Individual K8 and K18 bands were then pu- 
rified followed by tryptic peptide mapping. Small x indicates the origin where samples were loaded on the TLC plates. Arrowhead in a 
indicates higher turnover K8 phosphopeptide, and S52(d-f) indicates the ser52 phosphopeptide. For each map, 1,000 cpm were spotted, 
and the overall specific activity of radiolabeled K8 and K18 decreased progressively after the 3 then 6 h chase (not shown). (B) K18 was 
isolated from HT29 cells that were grown under four conditions: asynchronous  growth (G), heat stress (42°C, 24 h), G cells treated with 
okadaic acid (OA), or cells arrested at G2/M using colcemid (M) as described in Materials  and Methods.  Cells were labeled with 32po  4 
for the last 11 h of each condition. For OA treatment, the phosphatase inhibitor  was added during the last 2 h of labeling. Arrows indi- 
cate the ser52 phosphopeptide. 
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containing  epitope. (A) The 3055 Ab was generated and purified 
as described in Materials and Methods. Equal amounts of WT K18 
or ser52-~ala  K18 (S*), expressed then purified  from insect Sf9 
cells, were analyzed by immunoblotting using mAb CK5 (which 
recognizes phosphorylated  and nonphosphorylated  K18) and 3055 
antibody in the presence of excess phosphorylated or nonphos- 
phorylated peptide containing  ser52. (B) SDS detergent lysates 
(10 Ixg) from asynchronously  growing cells (G), cells arrested at 
the G2/M stage of the cell cycle using colcemid (M), heat stressed 
cells (42°C), or cells treated with OA for 2 h were separated by 
SDS-PAGE (lanes 1-4), transferred to a PVDF membrane then 
analyzed by immunoblotting using antibody 3055 (lanes 5-8) or 
antibodies  CK5 and L2A1. The Coomassie stain shown was done 
on the same PVDF membrane, after completion of the immuno- 
blotting.  (C)  K18  was  purified  from G  or  heat  stressed  cells. 
Equivalent amounts of purified  K18 were incubated alone or in 
the presence of potato acid phosphatase (PAP), and then analyzed 
by immunoblotting using CK5 or 3055 antibodies. 
after immunoblotting using the 3055  Ab in heat stressed, 
OA-treated and M  cells as compared with G  cells, while 
the  amount  of K18  analyzed was nearly equal  as  deter- 
mined by immunoblotting using L2A1  and CK5 antibod- 
ies. The purified 3055  Ab is highly specific and recognizes 
only the ser52 phosphorylated K18 among the large pool 
of proteins in the solubilized cellular protein lysate (Fig. 3 
B). Tryptic phosphopeptide mapping of K18 isolated from 
32pOa-labeled G, M, 42°C and OA-treated cells all showed 
that $52 is a labeled phosphopeptide (Fig. 2 B), albeit the 
overall pattern  of K18 tryptic phosphopeptides  for each 
condition differed somewhat. Although ser52 phosphory- 
lation increased during heat stress (Fig. 3 B), the relative 
increase is not  as high as the increase in other phospho- 
peptides since tryptic phosphopeptide mapping (Fig. 2 B) 
shows that the ser52-containing phosphopeptide is not the 
major labeled phosphopeptide (compare b in Fig. 2 B with 
a, c, and d). 
Third, to further validate that it is in fact the phosphate 
on ser52 that is important for 3055  Ab reactivity, K18 was 
isolated from G  and 42°C stressed cells followed by potato 
acid phosphatase treatment which abolished 3055  Ab re- 
activity (Fig.  3  C, compare lanes a  and  b  with c  and d). 
Specificity of the 3055  antibody was also examined by im- 
munofluorescence staining of HT29 cells cultured at 37  ° or 
42°C.  As shown in Fig. 4, reactivity with the 3055  Ab un- 
der  both conditions  was abolished  in  the  presence of the 
phosphopeptide (c and g with insets showing nuclear dou- 
ble  staining  of the  corresponding  panels)  but  not  in  the 
presence of the peptide (d and h). Neither the peptide nor 
the phosphopeptide  have any effect on the  immunofluo- 
rescence staining pattern obtained using L2A1 on CK5 an- 
tibodies (not shown). As we reported previously (Liao et 
al., 1995b), heat stress results in significant reorganization 
of K8/18 filaments as exemplified byfand h in Fig. 4. Dou- 
ble  staining  with  3055  and  L2A1  (or  CK5)  antibodies 
showed that the 3055 Ab preferentially recognized reorga- 
nized filaments of heat stressed cells (not shown but see 
Fig. 7). Although the 3055  Ab is monospecific with regard 
to its binding to phospho-ser52 of K18, it also does react 
(by immunoblotting) with a 66-kD epidermal keratin only 
after incubation of cultured keratinocytes with okadaic acid 
(not shown). 
Isoelectric Focusing/SDS-PA GE Analysis of 
Keratin Phosphorylation 
We examined the phosphorylated isoforms of K18 by com- 
paring the in vivo labeled species with species that are rec- 
ognized by the 3055  Ab. In vivo 32po  4 labeling of K18 re- 
sults in one major and three minor phosphorylated species, 
whereas 3055  Ab  immunoblotting  shows  two  major and 
two minor ser52 phosphorylated K18 species (Fig. 5). This 
analysis indicates that a significant fraction of phosphory- 
lated K18 has ser52 phosphorylation but that other minor 
phosphorylated  K18  populations  occur  which  are  either 
preferentially  phosphorylated  at  sites  other  than  ser52 
(e.g. fourth K18 Coomassie stained spot from left in Fig. 5 
B) or that are phosphorylated on ser52 as well as on other 
sites (see schematic in Fig. 5 B). Similar to K18, analysis of 
the overall K8 and K19 phosphorylation (K8/18/19 coim- 
munoprecipitate) showed that the major protein fractions 
of K8 and K19 are not phosphorylated (Fig. 5). We do not 
know the nature  of the difference between the  two non- 
phosphorylated forms of K18 shown in Fig. 5 B. The more 
Liao et al. Human Keratin 18 Phosphorylation  Dynamics  1295 Figure 4.  Immunofluorescence of HT29 cells using L2A1 and 3055 antibodies.  HT29 cells were cultured  at 37  ° or 42°C (24 h) on cover 
slips, rinsed, and then fixed with 100% methanol for 3 min (-20°C). Fixed cells were incubated with mAb L2A1 or with 3055 Ab (10 Ixg/ 
ml) alone or in the presence of excess nonphosphorylated or phosphorylated peptide (200 txg/ml). After 30 min, cells were rinsed fol- 
lowed by incubating with RNase A and the DNA staining dye YO-PRO1, and Texas red conjugated goat anti-mouse or goat anti-rabbit 
antibodies  as described in Materials  and Methods. Insets  in c and g reflect nuclear double staining. 
acidic nonlabeled isoform is noted particularly after Emp 
solubilization and is not usually seen after NP-40 solubili- 
zation  (not  shown).  It could  represent  a  hitherto  unde- 
fined charged modification (e.g., sulfation) or a very slow 
turnover non-ser52 phosphorylation site. 
Analysis of K18 ser52 Phosphorylation during Cell 
Cycle Progression 
We previously showed that K8/18 overall phosphorylation 
increases during the S and G2/M stages of the cell cycle in 
cells synchronized by G1/S aphidicolin block followed by 
release of the block (Chou and Omary, 1994).  We tested 
K18 ser52 phosphorylation during different stages of the 
cell cycle by immunoblotting cell lysates with the 3055 Ab. 
As shown in Fig. 6,  the peak of cells at the  S  and G2/M 
phases of the cell cycle was after 7 and 12 h after removing 
the aphidicolin, respectively, and corresponded to a three- 
fold  (S  phase  enriched  cells,  lane 3)  and  fourfold  (G2/M 
phase enriched cells, lane 4) increase in ser52 phosphory- 
lation. The increase in ser52 phosphorylation is reversible 
as cells exit from the G2/M stage (Fig. 6, lanes 5 and 6). 
We then compared the arrangement of K8/18 filaments 
during different stages of mitosis, as determined by immu- 
nostaining  using  L2A1  or  3055  antibodies.  As  shown  in 
Fig.  7 A, staining  of mitotic cells using the  3055  Ab was 
much brighter than the background nonmitotic cell stain- 
ing  which  was  a  reflection  of  the  observed  increase  in 
ser52  phosphorylation  of K18  (Fig.  6).  In  addition,  the 
3055  Ab  preferentially  recognized  the  reorganized  ilia- 
ments which cannot be appreciated using mAb CK5 (not 
shown) and mAb L2A1 (Fig. 7 A) which recognize the to- 
tal keratin pool. Preferential binding to reorganized fila- 
ments was also confirmed by double staining using L2A1 
and 3055  antibodies (Fig. 7 B). Omission of the 3055  and 
L2A1  antibodies  provided blank  staining  similar  to  that 
shown in c and g of Fig. 4 (not shown). 
Polarity of Phospho-ser52 KI  8 in Tissues 
We tested if a  unique  distribution  of the phosphorylated 
K18 fraction can be identified  in tissues,  as compared to 
the  overall phosphorylated  and  nonphosphorylated  K18 
pools. As shown in Fig. 8 (b and d), staining of human liver 
and pancreas with the 3055  Ab showed preferential local- 
ization to the basolateral and apical membrane domains, 
respectively. This contrasts with the membrane and cyto- 
plasmic staining observed with the L2A1 antibody (Fig. 8, 
a  and  c)  and  CK5  antibody (not  shown).  Similar results 
were observed using transgenic mice that overexpress nor- 
mal human K18 (Fig. 8, i-l). Interestingly, this polarity of 
phospho-K18 distribution was not observed in all tissues. 
For example, human kidney and colon did not show the 
polarity of distribution of the phospho-ser52 K18 (Fig. 8, 
e-h), which was also the case in transgenic mouse kidney 
and  intestinal  tissues  (not  shown).  The  immunofluores- 
cence results shown in Fig. 8 do not take into account the 
potential presence of any soluble phospho-ser52-K18 which 
would provide a diffuse staining pattern. We were not able 
to  make  use  of the  antibody  to  the  nonphosphorylated 
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Figure 5.  Two dimensional gel analysis  of keratin phosphoryla- 
tion. (A) Asynchronously growing HT29 cells were labeled with 
32po  4 for 11 h followed by immunoprecipitation of K8/18/19 us- 
ing mAb L2A1. Immunoprecipitates were analyzed by isoelectric 
focusing (IEF) in the horizontal direction then SDS-PAGE in the 
vertical direction. The gel was then transferred to a PVDF mem- 
brane followed by immunoblotting using the 3055 antibody, fol- 
lowed by Coomassie staining then autoradiography of the same 
membrane. (B) Given that the same membrane (A) was used for 
the  analyses  shown,  a  qualitative  schematic  was  generated  to 
show the relative Coomassie intensity,  32po  4 incorporation, and 
3055 Ab reactivity of K8,  K18 and K19.  Bold squares, relative 
Coomassie staining intensity; +, relative,  32po  4 incorporation; *, 
relative 3055 immunoblot intensity. 
ser52-containing  peptide  that we generated  since despite 
using two rabbits  and purification of the antibody with  a 
peptide  conjugated  column,  it  still  recognized  K18  plus 
two other major crossreacting bands (not shown). 
Figure 6.  Phosphorylation of K18 ser52  increases  during the S 
and G2/M phases of the cell cycle. Asynchronously growing HT29 
cells (lane 1) were cultured in the presence of aphidicolin (5 ~g/ 
ml) for 24 h which results in cell block at G1/S. Cells were then 
split  1:3 and cultured in the absence of aphidicolin for the indi- 
cated times.  At each time point, one dish was used for cell cycle 
analysis  and a duplicate dish  was used for immunoblotting with 
CK5 or 3055 antibodies. Equal amounts of protein (10 I~g) were 
analyzed for each lane.  The increase  in ser52  phosphorylation 
level was determined by comparing the densitometric scanning of 
lanes 2--4 with a standard curve of increasing concentration of cell 
lysate separated on the same gel (not shown). 
Discussion 
Dynamics of K8118 Phosphorylation 
Of  the  cytoplasmic  IF  proteins,  keratins  and  neurofila- 
ments  are  unique  in that  they form obligate  heteropoly- 
mers.  The  neurofilament  heteropolymers  consist  of  the 
light  (L), middle  (M),  and heavy (H) chains.  Both type I 
and type II keratin chains are phosphorylated with type II 
being generally more heavily phosphorylated than  type I 
keratins (e.g., Yano et al., 1991b; Chou and Omary, 1993), 
and similarly, all NF chains are phosphorylated with NF-H 
having  the  highest  stoichiometry  of  phosphorylation 
(Julien  and  Mushynski,  1983).  Several  phosphorylation- 
related features are shared between NF and K8/18. For ex- 
ample,  phosphorylation  is  preferentially  localized  to  the 
head domain of K18 (Chou and Omary, 1993), or the head 
and tail domains in NF-L, M, H  (reviewed by Nixon and 
Sihag, 1991), and K8 (Chou and Omary, 1993; and unpub- 
lished  observations).  These  are  the  domains  that  impart 
most  of the  structural  heterogeneity  among  IF proteins 
and hence are likely to be involved in regulating their tis- 
sue  specific function(s)  (reviewed  in  Steinert  and  Roop, 
1988; Fuchs and Weber, 1994). In addition, the turnover of 
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using L2A1 and 3055 antibodies.  (A) HT29 cells were fixed 12 h 
after splitting a confluent  dish 1:3 (to obtain exponential growth) 
or after an aphidicolin  block then 12 h release.  Fixed cells were 
double stained using YO-PRO-1 iodide and L2A1 or 3055 Ab as 
described  in Materials  and Methods.  (B) HT29 cells were double 
stained  with L2A1 and 3055 antibodies  followed by the addition 
of a mix of FITC goat anti-rabbit antibody (for the 3055 Ab) and 
Texas red goat anti-mouse antibody (for L2A1). For each double 
staining in A and B, pictures were taken from an identical field. 
phosphorylation of NF varies among the individual NF-L, 
M, and H  chains as does the phosphorylation turnover be- 
tween K8 and K18. For example, the turnover of phospho- 
rylation in NF-L and NF-M is significantly faster than that 
in NF-H (Sihag and Nixon, 1991).  With regard to K8 and 
K18,  although  the  stoichiometry  of phosphorylation  is 
K8  >  K18 (Fig. 5), the percent turnover of phosphoryla- 
tion is K18 >  K8 (Fig. 1). This suggests that phosphoryla- 
tion of K8 may not  be always intimately tied with phos- 
phorylation of K18, and that modification of each keratin 
is likely to play separate functions. To that end, we previ- 
ously observed that mutation of ser52 of K18 does not af- 
fect the  overall phosphorylation of K8 or the  individual 
labeled phosphopeptides (Ku and Omary, 1994). Further- 
more, although phosphorylation of K8 and K18 increased 
by similar proportion under conditions such as heat stress 
(Liao et al., 1995b), G2/M arrest (Chou and Omary, 1993), 
and progression through the cell cycle (Chou and Omary, 
1994), there are several examples where alteration of the 
type II keratin (e.g., K8) appears to occur preferentially. 
These include hyperphosphorylation of the type II keratin 
upon stimulation of cultured rat hepatocytes with epider- 
mal growth factor (Baribault et al.,  1989),  stimulation of 
human  amniotic  cells  by  pro-urokinase  (Busso  et  al., 
1994), or during meiotic maturation in the Xenopus oocyte 
(Klymkowsky et al., 1991).  However, depending on the ef- 
ficiency of radiolabeling, it may be difficult to appreciate a 
change  in  K18  phosphorylation  under  conditions  where 
immunopurification of K8/18 is not done, since incorpora- 
tion of 32po  4 into K18 is limited as compared with K8. 
Use of  Anti-phospho-epitope Antibodies to Study 
Protein Phosphorylation 
The purified 3055 Ab described in this study is highly spe- 
cific to the phospho-ser52 epitope (Figs. 3-5). Purification 
of the  antibody was essential since the  nonpurified  3055 
Ab cross-reacted with two other  unknown  proteins  (not 
shown). Although set52 is a major phosphorylation site of 
K18, several other phosphopeptides are noted after label- 
ing to equilibrium with 32po  4 (Fig. 2 A). Immunoblotting 
of isoelectrically separated  K18  isoforms that  were  pre- 
labeled with 32po  4 showed that all the isoforms contained 
ser52 phosphorylation but that one isoform had preferen- 
tial phosphorylation at other site(s) (Fig. 5). 
Several studies described the use of antibodies targeted 
to serine-containing  specific phospho-epitopes (reviewed 
by Czernik et al., 1991).  These include  the generation of 
monoclonal (Yano et al., 1991a) and polyclonal antibodies 
(Nishizawa et al., 1991; Matsuoka et al., 1992)  targeted to 
GFAP phospho-epitopes, and antibodies to the phospho- 
KSPV  motif in  tau  protein  (Lee  et  al.,  1991),  and  to  a 
vimentin  phospho-epitope  (Tsujimura  et  al.,  1994).  The 
epitopes for these  antibodies  were predesigned  and  well 
defined in  contrast to antibodies  that were  generated  to 
phosphorylated NF whose epitopes were not known. Ex- 
amples  of  the  latter  include  antibodies  that  recognize 
phospho-NF-L where the immunogen was a hypothalamic 
tissue  homogenate  (Sternberger  and  Sternberger,  1983), 
or antibodies that recognize NF-M,H where the immuno- 
gen was purified NF  (Lee et  al.,  1987).  Antibodies  that 
specifically recognize phosphotyrosine containing epitopes 
have  also  been  described  which  include  an  epitope  on 
c-erb (Epstein at al., 1992;  Bangalore et al., 1992; DiGio- 
vanna  and  Stern,  1995)  or  an  epitope  to  13-integrin  (Jo- 
hansson et al., 1994).  In general, these phosphoserine and 
phosphotyrosine-containing  epitope  tailored  antibodies 
are  extremely  specific  reagents  that  recognize  only  the 
phosphorylated residue in the context of an epitope (e.g., 
Figs.  3  and  4),  and  are  blocked  by the  phosphopeptide 
used for immunization but not by the phosphoamino acid. 
Such phospho-epitope specific antibodies can even distin- 
guish between two adjacent phosphorylated serine or thre- 
onine  as  demonstrated  for  polyclonal  antibodies  to  the 
epitopes... RAS*TI ... and ... RAST*I ... of phospho- 
lamban (Drago and Colyer, 1994). 
Dynamics and Significance of K18 ser52 
Phosphorylation 
Several observations indicate that ser52 of K18 is a highly 
dynamic phosphorylation site. First, short-term labeling (3 
h) of tissue cultured cells or normal colonic biopsies with 
32po  4 results in 80 or 95% of the K18 radiolabeled counts 
being incorporated into ser52, respectively (Ku and Omary, 
1994).  Second,  ser52 phosphorylation increases three- to 
The Journal of Cell Biology,  Volume 131, 1995  1298 Figure 8.  Polarity of phosphorylated keratin distribution  in human and mouse tissues. Normal human liver, pancreas, colon and kidney, 
or liver and pancreas tissues from transgenic mice expressing WT human K18 were used as described in Materials  and Methods. Tissues 
were snap frozen in O.C.T., sectioned,  and then stained with mAb L2A1 or with the 3055 Ab (30 min). After washing, sections were in- 
cubated with Texas red--conjugated  goat anti-mouse or anti-rabbit antibodies.  Similar staining to that with L2A1 was observed when 
mAb CK5 was used (not shown). 
fourfold during the S and G2/M phase of the cell cycle in a 
reversible manner  (Fig.  6),  with  subsequent  decrease  in 
phosphorylation  as  cells  exit  G2/M  and  enter  G1.  One 
likely function for this increase in phosphorylation is a role 
in the reorganization of the keratin filaments. In support 
of this, ser52~ala mutation interferes with the  ability of 
K8/18 filaments to reorganize in transfected cells arrested 
in G2/M or treated with OA (Ku and Omary, 1994). Fur- 
thermore,  the  3055  Ab  preferentially recognizes  reorga- 
nized filaments during mitosis (Fig. 7) thereby further sup- 
porting a  role for K18 ser52 phosphorylation in filament 
reorganization.  The  contribution  to  filament reorganiza- 
tion of other K18 or K8 phosphorylation sites remains to 
be determined as these sites become identified  and stud- 
ied.  Third, peptide mapping of pulse-chased  K18, that is 
metabolically labeled with 32po4, shows that ser52 of K18 
is a rapid turnover phosphorylation site (Fig. 2 B). 
Our results support several potential functions for K18 
ser52 phosphorylation. One function is filament reorgani- 
zation as mentioned above. A  second function is to dictate 
specific localization domains of K8/18 in polarized cells of 
the pancreas and liver. Such a potential function will still 
need  additional  supportive data.  However, the  preferen- 
tial  localization  of phospho-ser52-K18  in  the  basolateral 
domain  of hepatocytes  and  apical  domain  of pancreatic 
cells suggests  that  the  phospho-ser52-K18 fraction inter- 
acts  with  specific cellular  elements  that  are  localized  in 
these  domains,  and  that  the  phosphorylation of ser52  is 
important for that interaction. The nature of such putative 
domain-specific K8/18 interacting elements remains to be 
determined  (see below). Specificity of this localization is 
supported by its lack of distribution in all tissues. It is not 
clear  at  this  stage why  a  polar  distribution  of phospho- 
ser52 K18 was found in the liver and pancreas but not in 
the kidney or colon (Fig. 8). It is possible that phosphory- 
lation  of sites  other  than  ser52  of K18  (on  K8  or  K18) 
would  impart a  polar distribution  of the  phosphorylated 
species in the colon and kidney that is similar to what we 
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Alternatively,  the  "elements"  that  interact  with  ser52- 
phosphorylated K18 may not be present or are not polar- 
ized in the colon and kidney under the conditions exam- 
ined. A  third function is to alter K8/18 solubility which in 
turn  increases  the  level  of cytoplasmic nonfilamentous, 
nonmembrane-associated  K8/18  that  may  interact  with 
other soluble proteins such as heat shock protein 70 (Liao 
et al.,  1995a). Although we do not have direct evidence 
that specific phosphorylation at ser52 of K18 affects solu- 
bility of K8/18, several examples of concurrent hyperphos- 
phorylation of K8 and K18 (with increased phosphoryla- 
tion  at  ser52;  Fig.  3  B)  correlate with  increased  K8/18 
solubility. These examples include heat stress (Liao et al., 
1995a,b), colcemid arrest at G2/M (Chou et al., 1993), and 
treatment with okadaic acid (not shown). 
Potential Implications  for the Polarity of  Distribution of 
Phosphoryiated Cytoplasmic IF Proteins 
Epithelial cells and neurons have the common feature of 
polar cellular domains whereby some  neuronal proteins 
found in the axon differ from those found in the cell body 
and dendrites and, similarly, epithelial proteins found in 
the apical domain differ from those found in the basolat- 
eral domain (reviewed by Rodriguez-Boulan and Powell, 
1992; Matter and Mellman, 1994).  The polar distribution 
of phospho-ser52 K18 in some epithelial tissues (Fig. 8) is 
reminiscent  of the  polar  distribution  of phosphorylated 
NF in neurons (Sternberger and Sternberger, 1983; Lee et 
al., 1987). This suggests that other cytoplasmic IF proteins 
may manifest a similar polarity distribution of their phos- 
phorylated fraction. Such a hypothesis is attractive but will 
require additional testing in several systems. To that end, 
the restricted spatial distribution of phosphorylated ker- 
atins and NF in nondividing tissues parallels the spatiotem- 
poral distribution of phospho-thr7, ser13, ser34-GFAP at 
the cleavage furrow during cytokinesis in cultured astro- 
glioma cells (reviewed by Inagaki et al., 1994). 
The polarized staining  pattern  of liver and  pancreatic 
tissues with the 3055  Ab showed a  continuous nonpunc- 
tate pattern in proximity to the plasma membrane (Fig. 8). 
Several candidate proteins that may be involved in the in- 
teraction  with  phospho-ser52  K18  include  desmoplakin 
(DP), fodrin, or other cell surface associated proteins such 
as integrins. Although to our knowledge a fodrin-keratin 
interaction  has  not  been  described,  such  an  interaction 
would not be surprising given the polarized distribution of 
fodrin in epithelial cells (reviewed by Bennett and Gilli- 
gan, 1993), and the described association between fodrin 
and  other IF proteins including vimentin  (Mangeat  and 
Burridge,  1984),  NF  (Frappier et al.,  1987;  Langley and 
Cohen, 1987), and peripherin (Takemura et al.,  1993).  In 
addition, cell surface associated receptors could also po- 
tentially interact with the phospho-ser52 K18. For exam- 
ple, a high mannose and complex oligosaccharide-contain- 
ing 85-kD glycoprotein, that is likely to be a cell surface 
protein, associated with K8/18 (Chou et al.,  1994).  Also, 
different integrins show a polarized distribution in epithe- 
lial cells (De Luca et al.,  1990), with potential association 
of the  integrin  [34  subunit  with  the  keratin  fraction  in 
mouse carcinoma cell lines (Gomez et al., 1992).  With re- 
gard to DP, its association with keratins has been studied 
in several systems (e.g., Stappenbeck et al., 1993). To that 
end, a unique domain in several type II keratins was found 
to be important for binding to DP although this domain is 
not found in vimentin or K8/18 which are also known to 
bind to DP (Kouklis et al., 1994).  It is not known if phos- 
phorylation of K8/18 regulates their interaction with DP 
although phosphorylation of a serine in the COOH-termi- 
nal domain of DP interferes with its interaction with K8/18 
(Stappenbeck  et  al.,  1994).  Any  potential  role  for  K18 
ser52 phosphorylation in K8/18-DP interaction remains to 
be tested, but the known punctate staining pattern of DP 
(Pasdar and Nelson, 1988) suggests that the linear staining 
pattern  of phospho-ser52  K18 cannot be  exclusively ac- 
counted for by a phospho K18-DP interaction. 
Although cell polarity has been extensively studied in 
epithelial cells, all cells manifest some degree of polarity 
or  asymmetry (Matter  and  Mellman,  1994).  The use  of 
anti-phosphoepitope  antibodies  directed  to  IF  proteins 
should provide important functional information based on 
specific  polarity  or  spatiotemporal  cellular  distribution, 
and also provide a handle for studying the regulation of IF 
proteins. 
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